|
A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI) Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI) conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI) Clinical research trials and A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI) health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI). A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI) Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI) clinical trial. Test subjects typically receive the most expert healthcare available for their A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI) condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)  A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)
A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)
For Condition: Cardiovascular Diseases,Heart Diseases
Status: Completed
Sponsor(s): Eli Lilly and Company ,
Synopsis: The purpose of this study is to evaluate the effects of a drug known as CS-747 on subjects having a procedure called a percutaneous coronary intervention (also referred to as PCI) in which a doctor will attempt to open a blocked vessel (or vessels) in the heart using a catheter (a long thin tube) that has a small balloon on the end. In many cases, patients who have this procedure receive a stent, a small wire spring that helps keep the vessel open.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/75 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Patients must be candidates for elective or urgent PCI with intended coronary stenting. - Men or Non-pregnant women (that is, postmenopausal women, women who are surgically sterile, or women of childbearing potential who have a negative urine or serum pregnancy test) who are greater than or equal to 18 and less than or equal to 75 years of age. Exclusion Criteria: - Patients must not have planned PCI procedure as initial treatment for an acute ST-elevation acute myocardial infarction(STEMI) - Patients must not be receiving or will receive oral anticoagulation therapy that cannot be safely discontinued for the duration of the study - Patients must not have cardiogenic shock or severe congestive heart failure - Patients must not have active internal bleeding or history of bleeding diathesis - Patients must not have prior history of hemorrhagic cerebrovascular accident (CVA) or nonhemorrhagic CVA within 2 years of enrollment
Total Enrollment:
Location and Contact Information:
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Chattanooga, Tennessee,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Kalamazoo, Michigan,
United States
For information on a site near you, call our call center t 1-877-CTLILLY (1-877-285-4559)
Minneapolis, Minnesota,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Oceanside, California,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Charlotte, North Carolina,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Akron, Ohio,
United States
For information on a site near you, call our call center t 1-877-CTLILLY (1-877-285-4559)
Portland, Oregon,
United States
For information on a site near you, call our call center t 1-877-CTLILLY (1-877-285-4559)
Lansing, Michigan,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Boston, Massachusetts,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Jacksonville, Florida,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Fairfax, Virginia,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Sarasota, Florida,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
High Point, North Carolina,
United States
For information on a site near you, call our call center t 1-877-CTLILLY (1-877-285-4559)
Tupelo, Mississippi,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Tucson, Arizona,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Portland, Maine,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Rapid City, South Dakota,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Haddon Heights, New Jersey,
United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician."
Southfield, Michigan,
United States
Additional Information:
Study ID Numbers: 7145;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00059215
Other Heart Diseases Studies:
1. Platelet Drug Trial in Coronary Disease Progression
2. Heart Rate Recovery and Mortality
3. Cardiovascular Disease Trends 1980-91--A Gender Specific Perspective
4. Honolulu Heart Program
5. Studies of Left Ventricular Dysfunction (SOLVD)
Related Studies:
Other Heart Diseases Clinical Trials
Other California Clinical Trials
Other Oceanside Clinical Trials
A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)
|
|
|
|
|
|
|
|
